Blume was appointed to both the audit committee and the technology committee. Previously, Blume held the position of vice chairman for Deloitte, where she was a partner until retirement in 2015.
At Deloitte, Blume worked in a broad range of industries to transform business through the implementation of technology. Throughout her Deloitte career, she held numerous leadership positions, including serving as a member of the firm's US executive committee.
Centene provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.
Many receive benefits provided under Medicaid in addition to other state-sponsored programs, Medicare, dual eligible programs and programs with the US Department of Defense and US Department of Veterans Affairs.
The company also provides healthcare services to groups and individuals delivered through commercial health plans. It operates local health plans and offers a range of health insurance solutions.
Centene also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business